4.4 Article

Mechanism and dynamics of translesion DNA synthesis catalyzed by the Escherichia coli Klenow fragment

期刊

BIOCHEMISTRY
卷 47, 期 33, 页码 8527-8537

出版社

AMER CHEMICAL SOC
DOI: 10.1021/bi800324r

关键词

-

资金

  1. NCI NIH HHS [R01 CA118408, CA118408, R01 CA118408-04] Funding Source: Medline

向作者/读者索取更多资源

Translesion DNA synthesis represents the ability of a DNA polymerase to incorporate and extend beyond damaged DNA. In this report, the mechanism and dynamics by which the Escherichia coli Klenow fragment performs translesion DNA synthesis during the misreplication of an abasic site were investigated using a series of natural and non-natural nucleotides. Like most other high-fidelity DNA polymerases, the Klenow fragment follows the A-rule of translesion DNA synthesis by preferentially incorporating dATP opposite the noninstructional lesion. However, several 5-substituted indolyl nucleotides lacking classical hydrogen-bonding groups are incorporated similar to 100-fold more efficiently than the natural nucleotide. In general, analogues that contain large substituent groups in conjunction with significant pi-electron density display the highest catalytic efficiencies (k(cat)/K-m) for incorporation. While the measured K-m values depend upon the size and pi-electron density of the incoming nucleotide, k(cat) values are surprisingly independent of both biophysical features. As expected, the efficiency by which these non-natural nucleotides are incorporated opposite templating nucleobases is significantly reduced. This reduction reflects minimal increases in K. values coupled with large decreases in k(cat) values. The kinetic data obtained with the Klenow fragment are compared to that of the high-fidelity bacteriophage T4 DNA polymerase and reveal distinct differences in the dynamics by which these non-natural nucleotides are incorporated opposite an abasic site. These biophysical differences argue against a unified mechanism of translesion DNA synthesis and suggest that polymerases employ different catalytic strategies during the misreplication of damaged DNA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors

Xiumei Huang, Edward A. Motea, Zachary R. Moore, Jun Yao, Ying Dong, Gaurab Chakrabarti, Jessica A. Kilgore, Molly A. Silvers, Praveen L. Patidar, Agnieszka Cholka, Farjana Fattah, Yoonjeong Cha, Glenda G. Anderson, Rebecca Kusko, Michael Peyton, Jingsheng Yan, Xian-Jin Xie, Venetia Sarode, Noelle S. Williams, John D. Minna, Muhammad Beg, David E. Gerber, Erik A. Bey, David A. Boothman

CANCER CELL (2016)

Article Biochemistry & Molecular Biology

The Kub5-Hera/RPRD1B interactome: a novel role in preserving genetic stability by regulating DNA mismatch repair

Praveen L. Patidar, Edward A. Motea, Farjana J. Fattah, Yunyun Zhou, Julio C. Morales, Yang Xie, Harold R. Garner, David A. Boothman

NUCLEIC ACIDS RESEARCH (2016)

Article Genetics & Heredity

XRN2 Links Transcription Termination to DNA Damage and Replication Stress

Julio C. Morales, Patricia Richard, Praveen L. Patidar, Edward A. Motea, Tuyen T. Dang, James L. Manley, David A. Boothman

PLOS GENETICS (2016)

Article Oncology

Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents

Jung-Suk Choi, Seol Kim, Edward Motea, Anthony Berdis

ONCOTARGET (2017)

Article Biochemistry & Molecular Biology

Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers

Lifen Cao, Long Shan Li, Christopher Spruell, Ling Xiao, Gaurab Chakrabarti, Erik A. Bey, Kathryn E. Reinicke, Melissa C. Srougi, Zachary Moore, Ying Dong, Peggy Vo, Wareef Kabbani, Chin-Rang Yang, Xiaoyu Wang, Farjana Fattah, Julio C. Morales, Edward A. Motea, William G. Bornmann, John S. Yordy, David A. Boothman

ANTIOXIDANTS & REDOX SIGNALING (2014)

Article Biochemistry & Molecular Biology

Kub5-Hera, the human Rtt103 homolog, plays dual functional roles in transcription termination and DNA repair

Julio C. Morales, Patricia Richard, Amy Rommel, Farjana J. Fattah, Edward A. Motea, Praveen L. Patidar, Ling Xiao, Konstantin Leskov, Shwu-Yuan Wu, Walter N. Hittelman, Cheng-Ming Chiang, James L. Manley, David A. Boothman

NUCLEIC ACIDS RESEARCH (2014)

Review Biochemistry & Molecular Biology

Modulators of Redox Metabolism in Head and Neck Cancer

Xiaofei Chen, Jade Mims, Xiumei Huang, Naveen Singh, Edward Motea, Sarah M. Planchon, Muhammad Beg, Allen W. Tsang, Mercedes Porosnicu, Melissa L. Kemp, David A. Boothman, Cristina M. Furdui

ANTIOXIDANTS & REDOX SIGNALING (2018)

Article Oncology

NQO1-dependent, Tumor-selective Radiosensitization of Non-small Cell Lung Cancers

Edward A. Motea, Xiumei Huang, Naveen Singh, Jessica A. Kilgore, Noelle S. Williams, Xian-Jin Xie, David E. Gerber, Muhammad S. Beg, Erik A. Bey, David A. Boothman

CLINICAL CANCER RESEARCH (2019)

Review Oncology

Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy

Naveen Singh, S. Louise Pay, Snehal B. Bhandare, Udhaya Arimpur, Edward A. Motea

CANCERS (2020)

Article Multidisciplinary Sciences

XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition

Praveen L. Patidar, Talysa Viera, Julio C. Morales, Naveen Singh, Edward A. Motea, Megha Khandelwal, Farjana J. Fattah

SCIENTIFIC REPORTS (2020)

Review Oncology

Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer

Colton L. Starcher, S. Louise Pay, Naveen Singh, I-Ju Yeh, Snehal B. Bhandare, Xiaolin Su, Xiumei Huang, Erik A. Bey, Edward A. Motea, David A. Boothman

FRONTIERS IN ONCOLOGY (2020)

Article Cell Biology

Combined inhibition of Ref-1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co-culture models

Rachel A. Caston, Fenil Shah, Colton L. Starcher, Randall Wireman, Olivia Babb, Michelle Grimard, Jack McGeown, Lee Armstrong, Yan Tong, Roberto Pili, Joseph Rupert, Teresa A. Zimmers, Adily N. Elmi, Karen E. Pollok, Edward A. Motea, Mark R. Kelley, Melissa L. Fishel

Summary: This study investigates the synergistic effect of dual targeting Ref-1 and STAT3 pathways in cancer, showing promising results in inhibiting tumor growth and improving tumor response by hindering crosstalk between tumor and its microenvironment.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Chemistry, Multidisciplinary

Detecting Attomolar DNA-Damaging Anticancer Drug Activity in Cell Lysates with Electrochemical DNA Devices

Ashan P. Wettasinghe, Naveen Singh, Colton L. Starcher, Chloe C. DiTusa, Zakari Ishak-Boushaki, Dimithree Kahanda, Reema McMullen, Edward A. Motea, Jason D. Slinker

Summary: In this study, electrochemical DNA devices were used to quantify and understand the cancer-specific DNA-damaging activity of an emerging drug at extremely low concentrations. The results demonstrated the high potency and selectivity of the drug for NQO1+ cancer cells, and highlighted the potential of these devices in identifying promising drugs requiring improved cell permeability.

ACS SENSORS (2021)

Article Engineering, Biomedical

Aerosol delivery of stabilized polyester-siRNA nanoparticles to silence gene expression in orthotopic lung tumors

Yunfeng Yan, Kejin Zhou, Hu Xiong, Jason B. Miller, Edward A. Motea, David A. Boothman, Li Liu, Daniel J. Siegwart

BIOMATERIALS (2017)

Article Oncology

Kub5-Hera(RPRD1B) Deficiency Promotes BRCAness and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers

Edward A. Motea, Farjana J. Fattah, Ling Xiao, Luc Girard, Amy Rommel, Julio C. Morales, Praveen Patidar, Yunyun Zhou, Andrew Porter, Yang Xie, John D. Minna, David A. Boothman

CLINICAL CANCER RESEARCH (2018)

暂无数据